Stocks
By market cap · 57 stocks
- 1
ABTAbbottFreeStyle Libre, cardiovascular devices, diagnostics, and nutrition$178.18B+1.03% - 2
DHRDanaherBioprocessing, life-science, and clinical diagnostics portfolio$151.67B+1.14% - 3
NTRANateraMolecular testing across pregnancy, cancer, and organ health$53.08B+3.25% - 4
ILMNIlluminaSequencing and array platform with recurring consumables$36.13B+2.05% - 5
DGXQuest DiagnosticsClinical testing and diagnostic laboratory network$27.03B−4.67% - 6
PHGPhilips (ADR)Clinical imaging, connected care, and personal health$24.34B+0.24% - 7
GHGuardant HealthCancer blood tests for screening, monitoring, and treatment$23.33B+2.44% - 8
RVTYRevvityLife-science research and clinical diagnostics supplier$16.02B+0.07% - 9
TWSTTwist BioscienceSilicon-based DNA synthesis and sequencing tools$10.33B+2.63% - 10
BIOBio-Rad LaboratoriesDroplet digital PCR and clinical-lab systems$10.16B+0.32% - 11
QGENQIAGENSample-to-Insight molecular testing workflow provider$9.24B−1.76% - 12
GRFSGrifols (ADR)Integrated plasma therapies and diagnostics$6.23B+0.75% - 13
MMEDMiniMed GroupIntegrated insulin delivery and glucose monitoring$5.93B−0.27% - 14
HAEHaemoneticsPlasma collection and hospital blood-management devices$4.94B+0.19% - 15
BLLNBillionToOneMaker of prenatal and cancer genetic tests$4.78B+8.18% - 16
GRALGRAILDeveloper of Galleri multi-cancer blood screening$4.63B−2.21% - 17
ADPTAdaptive BiotechnologiesImmune-receptor sequencing for residual-disease testing$4.46B−2.24% - 18
CELCCelcuityDeveloper of REVTORPYK for advanced breast cancer$4.10B−1.48% - 19
VCYTVeracyteGenomic cancer tests from diagnosis through recurrence$3.31B+2.59% - 20
ALMRAlamar BiosciencesNULISA-based precision proteomics platform provider$2.43B+0.68% - 21
OPKOPKO HealthBioReference diagnostics and biopharma operator$1.26B+2.05% - 22
CBLLCeribellMaker of a bedside AI seizure-detection headband$920.1M+0.32% - 23
QDELQuidelOrthoDiagnostics maker behind VITROS analyzers and Sofia tests$740.6M+1.04% - 24
FLGTFulgent GeneticsGenetic-testing lab pairing diagnostics with a cancer-drug pipeline$611.7M+0.74% - 25
PREPrenetics GlobalIM8 supplements and CircleDNA consumer testing$413.8M−3.66% - 26
MYGNMyriad GeneticsBRCA-rooted molecular diagnostics portfolio$378.7M−0.37% - 27
CVCapsoVisionPanoramic capsule endoscopy for small-bowel imaging$309.3M−2.26% - 28
OSUROraSure TechnologiesOraQuick tests and sample-management devices$254.1M+5.28% - 29
NNNNAnbio BiotechnologyDesigner of decentralized diagnostic testing platforms$249.3M−2.78% - 30
BDSXBiodesixBlood-based lung diagnostics and development services$231.4M+1.27% - 31
XGNExagenAVISE diagnostics for autoimmune disease assessment$208.3M+1.99% - 32
TRIBTrinity Biotech (ADR)Diagnostics maker for HIV and haemoglobin testing$148.8M−1.22% - 33
FRNMFreenomeMultiomic blood tests for early cancer screening$135.4M−0.36% - 34
STXSStereotaxisRobotic magnetic navigation for cardiac electrophysiology$133.2M−0.74% - 35
IMDXInsight Molecular DiagnosticsMolecular testing for transplanted-organ rejection$129.5M+5.24% - 36
SERASeraPreterm-birth risk testing for pregnancy care$81.0M+3.77% - 37
STEXStreamexCommodity-tokenization infrastructure and PURE EP electrophysiology$75.0M+7.36% - 38
MDXHMDxHealthMolecular prostate-cancer testing menu$30.8M+0.62% - 39
QUCYQuantum CyberAutonomous defense drones and counter-UAS systems$30.1M+0.77% - 40
BNGOBionano GenomicsOptical genome mapping systems and workflow software$21.0M−3.82% - 41
AIFFFirefly NeuroscienceEEG assessment systems for clinical brain-function reports$18.2M+0.81% - 42
BNRBurning Rock Biotech (ADR)NGS cancer diagnostics and biopharma testing$15.6M+6.79% - 43
CNSYCerenomeCNS cancer diagnostics and targeted radiotherapy$13.1M+6.84% - 44
HSCSHeartSciencesAI-enabled ECG workflow platform and diagnostics developer$10.1M+6.41% - 45
ADVBAdvanced BiomedFinancial-market AI systems amid biomedical divestiture$8.9M+5.26% - 46
BMRABiomericaGI-focused diagnostics and rapid-test maker$8.0M+4.04% - 47
CDIOCardio DiagnosticsGenetic-epigenetic blood tests for coronary heart disease$5.7M+1.04% - 48
BIAFbioAffinity TechnologiesSputum-based lung diagnostics and pathology services$3.2M+11.69% - 49
VNRXVolitionRxNucleosome and chromatin-based blood diagnostics$2.2M−2.53% - 50
AMIXAutonomix MedicalTransvascular peripheral-nerve sensing and ablation platform$2.2M+1.23%

